antimüllerian hormone amh also known müllerianinhibiting hormone mih glycoprotein hormone structurally related inhibin activin transforming growth factor beta superfamily whose key roles growth differentiation humans encoded amh gene chromosome receptor encoded gene chromosome amh activated sertoli cells male expression inhibits development female reproductive tract müllerian ducts paramesonephric ducts male embryo thereby arresting development fallopian tubes uterus upper amh expression critical sex differentiation specific time fetal development appears tightly regulated nuclear receptor transcription gata factors sexreversal gene folliclestimulating hormone mutations amh gene type ii amh receptor shown cause persistence müllerian derivatives males otherwise normally amh also product granulosa cells preantral small antral follicles women amh present ovary production amh regulates folliculogenesis inhibiting recruitment follicles resting pool order select dominant follicle production amh product granulosa cells envelop egg provide energy amh also serve molecular biomarker relative size ovarian humans helpful number cells follicular reserve used predict timing bovine amh used selection females multiovulatory embryo transfer programs predicting number antral follicles developed amh also used marker ovarian dysfunction women polycystic ovary syndrome pcos amh dimeric glycoprotein molar mass molecule consists two identical subunits linked sulfide bridges characterized nterminal dimer proregion cterminal amh binds type receptor phosphorylates type receptor tgf beta signaling male mammals amh prevents development müllerian ducts uterus müllerian effect ipsilateral testis suppresses müllerian development humans action takes place first eight weeks gestation hormone produced gonads müllerian develop thanks presence wolffian ducts responsible male reproductive parts die due presence amounts amh measurable blood vary age sex amh works interacting specific receptors surfaces cells target tissues antimüllerian hormone receptors bestknown specific effect mediated amh type ii receptors includes programmed cell death apoptosis target tissue fetal müllerian ducts amh produced granulosa cells preantral antral follicles restricting expression growing follicles reached size differentiation state selected dominance action pituitary fsh ovarian amh expression observed early weeks gestation humans amh expression greatest recruitment stage folliculogenesis preantral small antral follicles expression diminishes follicles develop enter selection stage upon fsh expression authorities suggest measure certain aspects ovarian useful assessing conditions polycystic ovary syndrome premature ovarian amh production sertoli cells testes remains high throughout childhood males declines low levels puberty adult life amh shown regulate production sex changing amh levels rising females falling males may involved onset puberty sexes functional amh receptors also found expressed neurons brains embryonic mice thought play role sexually dimorphic brain development consequent development genderspecific clade sebastes rockfishes northwest pacific ocean duplicated copy amh gene called amhy master sexdetermining vitro experiments demonstrate overexpression amhy causes femaletomale sex reversal least one species males inadequate embryonal amh activity lead persistent müllerian duct syndrome pmds rudimentary uterus present testes usually undescended amh gene amh gene receptor amhrii usually abnormal amh measurements also become widely used evaluation testicular presence function infants intersex conditions ambiguous genitalia study published nature medicine found link hormonal imbalance womb polycystic ovary syndrome pcos specifically prenatal exposure antimüllerian study researchers injected pregnant mice amh higher normal concentration hormone indeed gave birth daughters later developed pcoslike tendencies included problems fertility delayed puberty erratic ovulation reverse researchers dosed polycystic mice ivf drug called cetrorelix made symptoms go away experiments confirmed humans could first step understanding relationship polycystic ovary antimüllerian hormone healthy females amh either detectable undetectable cord blood birth demonstrates marked rise three months age still detectable falls four years age rising linearly eight years age remaining fairly constant midchildhood early adulthood change significantly rise childhood adolescence likely reflective different stages follicle years age amh declines undetectable levels standard measurement amh follows generation ii assay give values previously used ibc assay amh values previously used dsl assay multiplied conform current standards used different weak evidence suggests amh measured early follicular phase variation menstrual cycle also amh levels decrease current use oral contraceptives current tobacco reference ranges antimüllerian hormone estimated reference groups united states females males amh measurements may less accurate person measured vitamin note males born higher amh levels females order initiate sexual differentiation women amh levels decrease time fertility decreases comparison individuals amh level respect average useful fertility assessment provides guide ovarian reserve identifies women may need consider either egg freezing trying pregnancy sooner rather later longterm future fertility higher level antimüllerian hormone tested women general population found positive correlation natural fertility women aged aiming conceive spontaneously even adjusting however correlation found comparable study younger women aged amh predictor ovarian response vitro fertilization ivf measurement amh supports clinical decisions alone suitable predictor ivf additionally amh levels used estimate womans remaining egg according nice guidelines vitro fertilization antimüllerian hormone level less equal pmoll ngml predicts low response gonadotrophin stimulation ivf level greater equal pmoll ngml predicts high cutoff values found literature vary pmoll ngml low response ovarian subsequently higher amh levels associated greater chance live birth ivf even adjusting amh thereby used rationalise programme ovulation induction decisions number embryos transfer assisted reproduction techniques maximise pregnancy success rates whilst minimising risk ovarian hyperstimulation syndrome amh predict excessive response ovarian hyperstimulation sensitivity specificity measuring amh alone may misleading high levels occur conditions like polycystic ovarian syndrome therefore amh levels considered conjunction transvaginal scan ovaries assess antral follicle ovarian studies treatments improve low ovarian reserve low amh levels met success current best available evidence suggests dhea improves ovarian function increases pregnancy chances reducing aneuploidy lowers miscarriage studies dhea low amh show dose mg period weeks taken improvement oocyteembryo quality dhea supplementation potentially suggests new concept ovarian aging ovarian environments oocytes age dhea positive outcomes women amh levels ngml dhea apparent effect oocytes ovarian environments range studies supplementation aged animal model delayed depletion ovarian reserve restored oocyte mitochondrial gene expression improved mitochondrial authors note replicate weeks using supplements mice achieve results would equivalent decade vitamin believed play role amh regulation amh gene promoter contains vitamin response element may cause vitamin status influence serum amh levels women levels vitamin nmoll show times better success rate ivf procedure low levels nmoll vitamin deficiency considered serum amh levels obtained women cancer radiation therapy chemotherapy damage ovarian reserve cases pretreatment amh useful predicting longterm postchemotherapy loss ovarian function may indicate fertility preservation strategies oocyte posttreatment amh associated decreased granulosa cell tumors ovary secrete amh amh testing sensitivity ranging diagnosing amh also useful diagnosing recurrence granulosa cell veterinary medicine amh measurements used determine neutering status male female dogs cats amh levels also used diagnose cases ovarian remnant polycystic ovary syndrome pcos endocrine disorder commonly found women reproductive age characterized oligo anovulation hyperandrogenism polycystic ovaries endocrine disorder increases amh levels nearly two three times higher women pcos normal type women often attributed increased follicle count number characteristic pcos indicating increase granulosa cells since surround individual however increased amh levels also attributed increased number follicles also increased amount amh produced per high levels androgens characteristic pcos also stimulate provide feedback increased production amh way amh increasingly considered tool biomarker used diagnose indicate pcos turner syndrome common sex chromosomerelated inherited diseases female around world incidence live female one significant pathological features premature ovarian failure leading amenorrhea even infertility follicle stimulating hormone inhibin b recommended monitored routinely specialists speculate condition ovary recently antimüllerian hormone advised accurate biomarker follicular development several researchers biological function antimüllerian hormone ovary counteract recruitment primordial follicles triggered fsh reserving follicle pool recruitment ovulation menopause takes place serum concentration antimüllerian hormone nearly undetectable amongst normal women thus variations amh levels childhood may theoretically predict duration given girls reproductive life span assuming speed continuous follicle loss comparable amh synthesized ability inhibit growth tissue derived müllerian ducts raised hopes usefulness treatment variety medical conditions including endometriosis adenomyosis uterine cancer research underway several laboratories standardized amh assays could potentially used biomarker polycystic ovary mice increase amh shown reduce number growing follicles thus overall size ovaries increase amh production reduces primary secondary antral follicles without reducing number primordial follicles suggesting blockade primordial follicle activation may provide viable method contraception protects ovarian reserve oocytes chemotherapy without extracting body allowing potential natural reproduction later adjective müllerian written either müllerian müllerian depending governing style guide derived term prefix anti antimüllerian antimüllerian antimüllerian müllerian ducts named johannes peter list names used antimüllerian hormone follows sake simplicity list ignores orthographic variations example gives one row müllerianinhibiting hormone although four acceptable stylings thereof capital lowercase hyphen space